Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38150285)

  • 1. Longitudinal adherence to annual colorectal cancer screening among Black persons living in the United States enrolled in a community-based randomized trial.
    Arevalo M; Sutton SK; Abdulla R; Christy SM; Meade CD; Roetzheim RG; Gwede CK
    Cancer; 2024 May; 130(9):1684-1692. PubMed ID: 38150285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings.
    Christy SM; Davis SN; Williams KR; Zhao X; Govindaraju SK; Quinn GP; Vadaparampil ST; Lin HY; Sutton SK; Roethzeim RR; Shibata D; Meade CD; Gwede CK
    Cancer; 2016 Nov; 122(21):3288-3296. PubMed ID: 27420119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.
    Davis SN; Christy SM; Chavarria EA; Abdulla R; Sutton SK; Schmidt AR; Vadaparampil ST; Quinn GP; Simmons VN; Ufondu CB; Ravindra C; Schultz I; Roetzheim RG; Shibata D; Meade CD; Gwede CK
    Cancer; 2017 Apr; 123(8):1390-1400. PubMed ID: 27906448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the Durability of Colorectal Cancer Screening Awareness and Health Beliefs Among Medically Underserved Patients: Baseline to 12¬†months Post-Intervention.
    Christy SM; Sutton SK; Gwede CK; Chavarria EA; Davis SN; Abdulla R; Schultz I; Roetzheim R; Shibata D; Meade CD
    J Cancer Educ; 2019 Apr; 34(2):297-303. PubMed ID: 29177920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
    Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
    Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
    Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
    Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
    Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
    J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat Annual Colorectal Cancer Screening in Rural Community Clinics: A Randomized Clinical Trial to Evaluate Outreach Strategies to Sustain Screening.
    Davis TC; Rademaker A; Morris J; Ferguson LA; Wiltz G; Arnold CL
    J Rural Health; 2020 Jun; 36(3):307-315. PubMed ID: 31523848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multilevel, low literacy dual language intervention to promote colorectal cancer screening in community clinics in Florida: A randomized controlled trial.
    Christy SM; Sutton SK; Abdulla R; Boxtha C; Gonzalez P; Cousin L; Ewing A; Montoya S; Lopez D; Beehler T; Sanchez J; Carvajal R; Meade CD; Gwede CK
    Prev Med; 2022 May; 158():107021. PubMed ID: 35305995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.
    Nielson CM; Vollmer WM; Petrik AF; Keast EM; Green BB; Coronado GD
    J Gen Intern Med; 2019 Jun; 34(6):978-985. PubMed ID: 30684199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and Facilitators of Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC).
    Ylitalo KR; Camp BG; Umstattd Meyer MR; Barron LA; Benavidez G; Hess B; Laschober R; Griggs JO
    J Am Board Fam Med; 2019; 32(2):180-190. PubMed ID: 30850454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile messenger-initiated reminders improve longitudinal adherence in a community-based, opportunistic colorectal cancer screening program: A single-blind, crossover randomized controlled study.
    Lam TYT; Wu PI; Tang RSY; Luk AKC; Ng S; Sung JJY
    Cancer; 2021 Mar; 127(6):914-921. PubMed ID: 33216357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
    O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
    O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
    Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population.
    Ramai D; Etienne D; Ayide G; Fields PJ; Reddy M
    J Clin Gastroenterol; 2019; 53(10):744-749. PubMed ID: 30222644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing a small media intervention to increase colorectal cancer screening in primary care clinics.
    Melvin CL; Vines AI; Deal AM; Pierce HO; Carpenter WR; Godley PA
    Transl Behav Med; 2019 Jul; 9(4):605-616. PubMed ID: 30085287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.
    Duncan A; Turnbull D; Wilson C; Osborne JM; Cole SR; Flight I; Young GP
    BMC Public Health; 2014 Mar; 14():238. PubMed ID: 24606951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
    Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
    Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.